JAIME
LORA-TAMAYO MORILLO-VELARDE
Profesor asociado de Ciencias de la Salud
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (16)
2024
-
Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 208-214
2023
-
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study
Journal of Hospital Infection, Vol. 142, pp. 9-17
2022
-
Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study
Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1359-1366
-
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study—The ARTHR-IS Study Group
Infectious Diseases and Therapy, Vol. 11, Núm. 6, pp. 2177-2203
2021
-
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
Journal of Clinical Investigation, Vol. 131, Núm. 20
-
How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 11, pp. e3820-e3824
-
Implant removal in the management of prosthetic joint infection by staphylococcus aureus: Outcome and predictors of failure in a large retrospective multicenter study
Antibiotics, Vol. 10, Núm. 2, pp. 1-13
-
Prosthetic shoulder joint infection by Cutibacterium acnes: Does rifampin improve prognosis? A retrospective, multicenter, observational study
Antibiotics, Vol. 10, Núm. 5
-
The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 12, pp. e1064-e1073
2019
-
Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention
Journal of Infection, Vol. 78, Núm. 1, pp. 40-47
-
Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study
Journal of Infection, Vol. 79, Núm. 3, pp. 199-205
2018
-
Candida periprosthetic joint infection: A rare and difficult-to-treat infection
Journal of Infection, Vol. 77, Núm. 2, pp. 151-157
2016
-
Short- versus long-duration levofloxacin plus rifampicin for acute staphylococcal prosthetic joint infection managed with implant retention: a randomised clinical trial
International Journal of Antimicrobial Agents, Vol. 48, Núm. 3, pp. 310-316
-
Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8
2014
-
Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study
Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919
2013
-
A large multicenter study of methicillin-susceptible and methicillin-resistant staphylococcus aureus prosthetic joint infections managed with implant retention
Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 182-194